{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:09:39Z","timestamp":1765667379043,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.clinre.2022.101955","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T11:53:26Z","timestamp":1653134006000},"page":"101955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study"],"prefix":"10.1016","volume":"46","author":[{"given":"Francesco","family":"Caputo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Gelsomino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6955-7139","authenticated-orcid":false,"given":"Andrea","family":"Spallanzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Pettorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Benatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Ghidini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Grizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2120-1923","authenticated-orcid":false,"given":"Valeria","family":"Merz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-1419","authenticated-orcid":false,"given":"Carlo","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6202-0758","authenticated-orcid":false,"given":"Roberto","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Luppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Melisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Dominici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Salati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinre.2022.101955_bib0001","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.idc.2010.07.006","article-title":"Cholangiocarcinoma: new insights into disease pathogenesis and biology","volume":"24","author":"Braconi","year":"2010","journal-title":"Infect Dis Clin N Am"},{"issue":"6","key":"10.1016\/j.clinre.2022.101955_bib0002","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.clinre.2022.101955_bib0003","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in thc U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.clinre.2022.101955_bib0004","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2022.101955_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/liv.14100","article-title":"Medical treatment for cholangiocarcinoma","volume":"39","author":"Adeva","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2022.101955_bib0006","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.critrevonc.2019.09.002","article-title":"Adjuvant chemotherapy in resected bile duct cancer: a systematic review and meta-analysis of randomized trials","volume":"143","author":"Messina","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.clinre.2022.101955_bib0007","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1634\/theoncologist.9-1-43","article-title":"Diagnosis and treatment of cholangiocarcinoma","volume":"9","author":"Anderson","year":"2004","journal-title":"Oncologist"},{"issue":"14","key":"10.1016\/j.clinre.2022.101955_bib0008","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.clinre.2022.101955_bib0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.clinre.2022.101955_bib0011","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/bjc.2016.64","article-title":"Quality of life, long-term survivors and long-term outcome from the ABC-02 study","volume":"114","author":"Bridgewater","year":"2016","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.clinre.2022.101955_bib0012","doi-asserted-by":"crossref","first-page":"352","DOI":"10.21037\/jgo.2017.03.06","article-title":"Long term responders to palliative chemotherapy for advanced biliary tract cancer","volume":"8","author":"Doherty","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.clinre.2022.101955_bib0013","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/annonc\/mdv483","article-title":"Prognostic factors for progression-free and overall survival in advanced biliary tract cancer","volume":"27","author":"Bridgewater","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinre.2022.101955_bib0014","first-page":"428","article-title":"A population based analysis of prognostic factors in advanced biliary tract cancer","volume":"5","author":"Peixoto","year":"2014","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.clinre.2022.101955_bib0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00535-018-1518-3","article-title":"Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy","volume":"54","author":"Suzuki","year":"2019","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.clinre.2022.101955_bib0016","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.clinre.2022.101955_bib0017","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41416-019-0698-9","article-title":"Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial","volume":"122","author":"Belkouz","year":"2020","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.clinre.2022.101955_bib0018","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jamaoncol.2019.0270","article-title":"Gemcitabine, cisplatin, and nab-paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical trial","volume":"5","author":"Shroff","year":"2019","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.clinre.2022.101955_bib0019","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.sla.0000150166.94732.88","article-title":"Actual long-term outcome of extrahepatic bile duct cancer after surgical resection","volume":"241","author":"Jang","year":"2005","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.clinre.2022.101955_bib0020","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5152\/tjg.2019.18275","article-title":"Long-term Survival after resection for perihilar cholangiocarcinoma: impact of UICC staging and surgical procedure","volume":"30","author":"Juntermanns","year":"2019","journal-title":"Turk J Gastroentrol"},{"key":"10.1016\/j.clinre.2022.101955_bib0021","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejca.2019.05.030","article-title":"The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy","volume":"117","author":"Salati","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clinre.2022.101955_bib0022","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.ejca.2014.02.015","article-title":"Neutrophil\/lymphocyte ratio as a prognostic factor in biliary tract cancer","volume":"50","author":"McNamara","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clinre.2022.101955_bib0023","doi-asserted-by":"crossref","first-page":"36857","DOI":"10.18632\/oncotarget.16143","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.clinre.2022.101955_bib0024","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/liv.14314","article-title":"The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer","volume":"40","author":"Salati","year":"2020","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.clinre.2022.101955_bib0025","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.clinre.2022.101955_bib0026","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer","volume":"88","author":"Guthrie","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.clinre.2022.101955_bib0027","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1172\/JCI37223","article-title":"Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model","volume":"120","author":"Jablonska","year":"2010","journal-title":"J Clin Invest"},{"issue":"46","key":"10.1016\/j.clinre.2022.101955_bib0028","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.3748\/wjg.v16.i46.5790","article-title":"Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis","volume":"16","author":"Hofman","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"7203","key":"10.1016\/j.clinre.2022.101955_bib0029","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.clinre.2022.101955_bib0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clinre.2022.101955_bib0031","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3892\/ijo.2016.3616","article-title":"Neutrophils in cancer development and progression: roles, mechanisms, and implications (Review)","volume":"49","author":"Zhang","year":"2016","journal-title":"Int J Oncol"},{"key":"10.1016\/j.clinre.2022.101955_bib0032","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ijc.24448","article-title":"IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer","volume":"125","author":"Rotondo","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clinre.2022.101955_bib0033","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3389\/fonc.2019.01146","article-title":"Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy","volume":"9","author":"Masucci","year":"2019","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.clinre.2022.101955_bib0034","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ijc.25397","article-title":"PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients","volume":"128","author":"Shi","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clinre.2022.101955_bib0035","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.1038\/s41598-018-27896-y","article-title":"The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer","volume":"8","author":"Li","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinre.2022.101955_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.745748","article-title":"Decrease in blood neutrophil-to-lymphocyte ratio indicates better survival after neoadjuvant chemotherapy in patients with advanced gastric cancer","volume":"8","author":"Liu","year":"2021","journal-title":"Front Surg"},{"issue":"12","key":"10.1016\/j.clinre.2022.101955_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications","volume":"9","author":"Churi","year":"2014","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.clinre.2022.101955_bib0038","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"24","key":"10.1016\/j.clinre.2022.101955_bib0039","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1002\/cncr.30254","article-title":"Biliary cancer: utility of next-generation sequencing for clinical management","volume":"122","author":"Javle","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clinre.2022.101955_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00080","article-title":"Cholangiocarcinoma with FGFR genetic aberrations: a unique clinical phenotype","volume":"2","author":"Jain","year":"2018","journal-title":"JCO Precis Oncol"},{"issue":"8","key":"10.1016\/j.clinre.2022.101955_bib0041","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.humpath.2014.03.014","article-title":"Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma","volume":"45","author":"Graham","year":"2014","journal-title":"Hum Pathol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740122000924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740122000924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:34:09Z","timestamp":1761896049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740122000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2210740122000924"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2022.101955","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2022.101955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101955"}}